Equity
€103,910 ▼ 43.2%
Lienwit paid out €182,059 in dividends. That is 177% of the 2025 profit.
Lienwit
Lifetime
4 annual accounts with figures on one time axispeak €136,092 (2025)
€136,092▲ 21.9%
peak €102,910 (2025)
€102,910▲ 20.9%
peak €183,059 (2024)
€103,910▼ 43.2%
€3,631▼ 86.2%
Board2 names since 2022
1 director
Documentsfilings and deeds
20-03-202641 days before the deadline
2025micro format
Gross margin from €111,666 to €136,092Dividend €182,059Equity from €183,059 to €103,910Debts from €26,381 to €3,631Cash from €57,954 to €31,049
Key points
from the 2025 annual accountsTurnover
≈ €270,000 estimated
The micro format states no turnover.
Liquidity
44.21 was 8.07 in 2024
Short-term debts fell from €24,452 to €2,165.
Filings
4 annual accounts since 2022
The last four annual accounts were filed 12 to 41 days before the end of the period.
Board
1 joined
New director. Latest change 05-06-2026 · 2 in office.
Position in the sector
96.6%
Higher solvency than 94% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as Lienwit has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for Lienwit. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Appointment: (director)
General meeting of 19-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0782541164
Incorporation
Founding capital of €1,000, 50 shares · Founder: · Appointment: (director) · published on 25-02-2022 · Gazette deed
First establishment
Lagebekeweg 1, Bruges
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Lienwit Jabbeke | €107,541 | €136,092 | 96.6% | - |
| Dr. Kimberly Parmentier Deerlijk | €113,049 | €125,608 | 4.7% | - |
| Huisartsennetwerk De Bosbeek As | €104,599 | €136,840 | 4.3% | - |
| Dr. Lieve Vercammen Holsbeek | €105,927 | €126,211 | 89.2% | - |
| Dr. B. Blancke, huisarts Brecht | €99,624 | €125,567 | 47.5% | - |
| Dokter Stefan Tanasijevic Antwerp | €121,777 | €128,730 | 4.1% | - |
| Elisoet Antwerp | €108,461 | €124,848 | 2.3% | - |
These companies have the same main activity as Lienwit: general medical practice (NACE 86210). They are comparable in size and age: total assets between €99,600 and €122,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 23-02-2022Normal situation
- Activity
- General medical practiceNACE 86210and 2 others
- Establishment unit
- 2.329.551.5058200 Bruges, since 23-02-2022
- Financial year end
- 30 September
- Peppol
- Reachable since 23-02-2024
Annual accounts to 30-09-2025
- €107,541▼ 48.7%
- Filing
- Filed on 20-03-2026, 41 days before the end of the filing period
Insights on Lienwit
Lienwit files the micro format. That format states no turnover. The gross margin rose from €59,362 in 2022 to €136,092 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Lienwit
- What is the company number of Lienwit?
- The company number of Lienwit is 0782.541.164. The VAT number is the same number with BE in front: BE 0782.541.164.
- Where is Lienwit based?
- The registered office is at Klaverveld 27, 8490 Jabbeke.Company details
- What does Lienwit do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Lienwit?
- Lienwit is a private limited company (BV).
- When was Lienwit founded?
- Lienwit was founded on 23-02-2022.
- Is Lienwit still active?
- Yes, Lienwit is an active enterprise in the KBO register.
- What is the turnover of Lienwit?
- The turnover in financial year 2025 is ≈ €270,000. This figure is estimated from the gross margin of €136,092 and 65 comparable companies (NACE 862). It probably lies between €200,000 and €340,000.Financials
- Is Lienwit profitable?
- In financial year 2025, Lienwit made a profit of €102,910.
- Where can I find the annual accounts of Lienwit?
- Lienwit filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Lienwit due?
- Lienwit must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.